Cited by 171Metabolism and Genetic DisordersHereditary Neurological DisordersNeurological diseases and metabolism

Identification of PEX7 as the second gene involved in Refsum disease

Open access
van den Brink, Daan M., Brites, Pedro, Haasjes, Janet, Wierzbicki, Anthony S., Mitchell, John, Lambert-Hamill, Michelle, de Belleroche, Jacqueline, Jansen, Gerbert A. +2 more·2003·The American Journal of Human Genetics

Abstract

Patients affected with Refsum disease (RD) have elevated levels of phytanic acid due to a deficiency of the peroxisomal enzyme phytanoyl-CoA hydroxylase (PhyH). In most patients with RD, disease-causing mutations in the PHYH gene have been identified, but, in a subset, no mutations could be found, indicating that the condition is genetically heterogeneous. Linkage analysis of a few patients diagnosed with RD, but without mutations in PHYH, suggested a second locus on chromosome 6q22-24. This region includes the PEX7 gene, which codes for the peroxin 7 receptor protein required for peroxisomal import of proteins containing a peroxisomal targeting signal type 2. Mutations in PEX7 normally cause rhizomelic chondrodysplasia punctata type 1, a severe peroxisomal disorder. Biochemical analyses of the patients with RD revealed defects not only in phytanic acid alpha-oxidation but also in plasmalogen synthesis and peroxisomal thiolase. Furthermore, we identified mutations in the PEX7 gene. Our data show that mutations in the PEX7 gene may result in a broad clinical spectrum ranging from severe rhizomelic chondrodysplasia punctata to relatively mild RD and that clinical diagnosis of conditions involving retinitis pigmentosa, ataxia, and polyneuropathy may require a full screen of peroxisomal functions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1086/346093

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Peripheral neuropathy has been reported in a clinical subset of RCDP patients.

    “In line with myelination defects also in the PNS, peripheral neuropathy has been reported in a clinical subset of RCDP patients [201].”

    From Peroxisomes in brain development and function (2016) · cites this paper as [201]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
van den Brink, D. M., Brites, P., Haasjes, J., Wierzbicki, A. S., Mitchell, J., Lambert-Hamill, M., de Belleroche, J., Jansen, G. A., Waterham, H. R., & Ronald Wanders, J. A.
Affiliations
  • Amsterdam UMC Location University of Amsterdam (NL)
  • St Thomas' Hospital (GB)
  • Charing Cross Hospital (GB)
Venue
The American Journal of Human Genetics
Publisher
Elsevier BV
Published
2003-02
Volume
72
Issue
2
Pages
471-477
ISSN
0002-9297 (ISSN-L)
OpenAlex
W2096184116
Cited by
171
References
34
Citations by year
2026: 4 · 2025: 6 · 2024: 7 · 2023: 3 · 2022: 6 · 2021: 7 · 2020: 8 · 2019: 8 · 2018: 6 · 2017: 6 · 2016: 10 · 2015: 4 · 2014: 9 · 2013: 4 · 2012: 10
FWCI
7.19
Type
journal article
Language
en
Open access
Locations
  • The American Journal of Human Genetics (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • UvA-DARE (University of Amsterdam) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
Refsum disease, PEX7, phytanic acid, peroxisomal disorders, rhizomelic chondrodysplasia punctata, plasmalogen synthesis, genetic heterogeneity, retinitis pigmentosa, ataxia, polyneuropathy, peroxisomal import
MeSH terms
Peroxisomal Targeting Signal 2 Receptor, Acetyl-CoA C-Acetyltransferase, Adult, Alleles, Cells, Cultured, Chromosomes, Human, Pair 6, Female, Fibroblasts, Humans, Mixed Function Oxygenases, Genetic Linkage, Male, Mutation, Phytanic Acid, Plasmalogens, Refsum Disease, Skin, Receptors, Cytoplasmic and Nuclear, Siblings

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review